Ipratropium

COPD ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27418820 Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. 2016 1
2 30715829 Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms. 2016 Nov 1
3 22409290 Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues. 2012 Apr 1
4 21311689 Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. 2010 Dec 31 2
5 15219176 A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. 2004 2
6 15500180 Long-term pharmacologic management of patients with chronic obstructive pulmonary disease. 2004 1
7 8549206 Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD. 1996 Jan 1
8 8549208 Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD. 1996 Jan 1
9 8658369 Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease. 1996 Jan 2
10 2145136 A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. 1990 Oct 2